etidronate has been researched along with Aortic Diseases in 10 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
Aortic Diseases: Pathological processes involving any part of the AORTA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Statins are not effective in reducing atherosclerotic plaques of the abdominal aorta, and accumulating evidence suggests that bisphosphonates have the potential to induce the regression of atherosclerotic plaques of the abdominal aorta." | 2.78 | Atorvastatin, etidronate, or both in patients at high risk for atherosclerotic aortic plaques: a randomized, controlled trial. ( Inazu, T; Kawahara, C; Kawahara, T; Nishikawa, M; Sakai, K; Suzuki, G, 2013) |
| " Our data show that ED at a dosage that suppresses bone metabolism markedly inhibits vascular calcification in rats with renal failure." | 1.33 | Effect of etidronate on aortic calcification and bone metabolism in calcitriol-treated rats with subtotal nephrectomy. ( Aizawa, S; Hashiba, H; Kogo, H; Suzuki, Y; Tamura, H; Tamura, K, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawahara, T | 1 |
| Nishikawa, M | 1 |
| Kawahara, C | 1 |
| Inazu, T | 1 |
| Sakai, K | 1 |
| Suzuki, G | 1 |
| King, A | 1 |
| Lomashvili, KA | 1 |
| Monier-Faugere, MC | 1 |
| Wang, X | 1 |
| Malluche, HH | 1 |
| O'Neill, WC | 1 |
| Neven, EG | 1 |
| De Broe, ME | 1 |
| D'Haese, PC | 1 |
| Tamura, K | 3 |
| Suzuki, Y | 2 |
| Hashiba, H | 2 |
| Tamura, H | 1 |
| Aizawa, S | 3 |
| Kogo, H | 3 |
| Matsushita, M | 1 |
| Fujii, H | 1 |
| Miyaura, C | 1 |
| Zhu, BQ | 1 |
| Sun, YP | 1 |
| Sievers, RE | 1 |
| Isenberg, WM | 1 |
| Moorehead, TJ | 1 |
| Parmley, WW | 1 |
| Price, PA | 1 |
| Faus, SA | 1 |
| Williamson, MK | 1 |
| Kingma, JG | 1 |
| Roy, PE | 1 |
2 trials available for etidronate and Aortic Diseases
| Article | Year |
|---|---|
Atorvastatin, etidronate, or both in patients at high risk for atherosclerotic aortic plaques: a randomized, controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Aorta, Abdominal; Aorta, Thoracic; Aortic Diseases; Atorvastatin; Bo | 2013 |
Inhibition of the progression of aortic calcification by etidronate treatment in hemodialysis patients: long-term effects.
Topics: Aortic Diseases; Bone Density; Bone Density Conservation Agents; Calcinosis; Disease Progression; Et | 2006 |
8 other studies available for etidronate and Aortic Diseases
| Article | Year |
|---|---|
Vascular disease: aortic plaque--dual therapy for a heterogeneous disease.
Topics: Aortic Diseases; Calcinosis; Etidronic Acid; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl- | 2013 |
Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure.
Topics: Animals; Aortic Diseases; Bone and Bones; Bone Resorption; Calcification, Physiologic; Calcinosis; D | 2009 |
Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge?
Topics: Animals; Aortic Diseases; Calcification, Physiologic; Calcinosis; Diphosphonates; Etidronic Acid; Hu | 2009 |
Effect of etidronate on aortic calcification and bone metabolism in calcitriol-treated rats with subtotal nephrectomy.
Topics: Amino Acids; Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Diseases; Body Weight; Bone and Bone | 2005 |
Prevention of aortic calcification by etidronate in the renal failure rat model.
Topics: Animals; Aortic Diseases; Bone Density; Calcinosis; Calcium; Calcium-Binding Proteins; Disease Model | 2007 |
Effects of etidronate and lovastatin on the regression of atherosclerosis in cholesterol-fed rabbits.
Topics: Animals; Aortic Diseases; Arteriosclerosis; Body Weight; Bone and Bones; Calcium; Diet, Atherogenic; | 1994 |
Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption.
Topics: Alendronate; Animals; Aortic Diseases; Bone Resorption; Calcification, Physiologic; Calcinosis; Diph | 2001 |
Effect of ethane-I-hydroxy-I, I-diphosphonate on arterial calcinosis induced by hypervitaminosis D: a morphologic investigation.
Topics: Animals; Aorta, Thoracic; Aortic Diseases; Calcinosis; Ergocalciferols; Etidronic Acid; Male; Micros | 1990 |